Predictors of favorable survival after secondary cytoreductive surgery for recurrent endometrial cancer
Authors:
- 16 May 2019
- journal article
- research article
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 24 (10) , 1256-1263
Abstract
The selection criteria for secondary cytoreductive surgery (SCS) for recurrent endometrial cancer (EC) remain to be defined. The present study aimed to identify predictors for favorable survival after SCS for the disease.Keywords
This publication has 20 references indexed in Scilit:
- Surgical Treatment of Recurrent Endometrial Cancer: Time for a Paradigm ShiftAnnals of Surgical Oncology, 2015
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Salvage cytoreductive surgery for patients with recurrent endometrial cancer: a retrospective studyBMC Cancer, 2014
- Salvage cytoreductive surgery for recurrent endometrial cancerGynecologic Oncology, 2006
- Surgical resection of recurrent endometrial carcinomaGynecologic Oncology, 2006
- Follow-up after primary therapy for endometrial cancer: A systematic reviewGynecologic Oncology, 2006
- Surgical treatment of recurrent endometrial carcinomaCancer, 2003
- Pelvic Exenteration for Recurrent Endometrial CancerGynecologic Oncology, 1999
- Maximal Cytoreductive Surgery as a Reasonable Therapeutic Alternative for Recurrent Endometrial CarcinomaGynecologic Oncology, 1998
- Treatment of Recurrent Adenocarcinoma of the Endometrium with Pelvic ExenterationGynecologic Oncology, 1996